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a b s t r a c t
Prostate carcinoma, when metastatic, typically involves bone and produces both osteoblas-
tic and osteolytic changes. A 73-year-old man was admitted to our department because of
unilateral progressive proptosis and visual blurriness for 3 months. The patient had a history
of prostate adenocarcinoma diagnosis 5 years ago. We report a case of orbital involvement
presented that intraorbital mass (including periocular structures), temporal bone and
temporal muscle from prostate cancer. The mass was removed with total excision. Despite
the frequency of bone metastasis in prostatic carcinoma, triple orbital metastases are
extremely rare. The best of our knowledge, prostate adenocarcinoma and its triple (temporal
bone, temporal muscle and intraorbital mass) orbital metastases have not been published
previously. Metastatic orbital tumor secondary to prostate cancer should be considered in
patients who have varying degrees of eye symptoms.
# 2016 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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The latest estimates of global cancer incidence show that
prostate cancer is the sixth most common cancer in the world
(in the number of new cases), the third most common cancer
in men, the most common cancer in men in Western
populations [1]. The most frequent metastatic sites in
prostate cancer are bone (85%), lymph nodes and further
visceral metastases (liver, central nervous system, lungs)
(45%) [2]. About 30% of patients with prostate cancer have
regional or distant metastasis at the time of diagnosis [3].
Bone metastases of prostatic cancer are the most common
form of distant spreading. The most frequent sites of bone
metastases are the pelvis and vertebrae [4]. Despite the
frequency of bone metastasis in prostatic carcinoma, orbital* Corresponding author at: Department of Neurosurgery, Eskisehir Aci
Eskisehir 26130, Turkey. Tel.: +90 505 3166500; fax : +90 222 2144400.
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0028-3843/# 2016 Polish Neurological Society. Published by Elsevier Smetastases are extremely rare [5]. We report a case of orbital
involvement presented that intraorbital mass (including
periocular structures), temporal bone and temporal muscle
from prostate cancer.
2. Case report
A 73-year-old man was admitted to our department because of
unilateral progressive proptosis, pain and visual blurriness for
3 months. The patient had a history of prostate adenocarci-
noma diagnosis 5 years ago. He underwent radical prostatec-
tomy. The maintenance androgen ablation was planned after
surgery. The patient received total androgen blockade with
luteinizing hormone releasing hormone analog and ﬂutamide.
Complete physical examination was normal except for thebadem Hospital, Eskibaglar cad., Acibadem sok. No: 19, Tepebası,
p. z o.o. All rights reserved.
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proptosis and ipsilateral visual loss were detected in ophthal-
mologic examination. Magnetic resonance imaging (MRI) of the
cranium and orbita showed that tumor divided two part one of
them – a lateral-orbital mass measuring 5 cm  3 cm and the
other intra orbital part is 3 cm  3 cm, and CT (computed
tomography) scan of orbita show that tumor metastases of
lateral orbital wall and sphenoid wings (Fig. 1A and B). There
were no other visceral metastases at presentation. Laboratory
examination was normal ranges. Only serum prostatic speciﬁc
antigen (PSA) level was 65.43 ng/mL. The mass was removed
with total excision. Histopathologic examination from theFig. 1 – (A and B) MRI of the cranium and orbita showed that
tumor divided two part one of them – a lateral-orbital mass
and the other intra orbital part. CT scan of orbita show that
tumor metastases of lateral orbital wall and sphenoid
wings.
Fig. 2 – Infiltration of adenocarcinoma cells in periorbital
fibrous tissue. In some tumor cells, focally positive PSA
immunostaining PSA T 40).orbital mass indicated a malignant epithelial tumor metastasis
that may have arose secondary to prostate carcinoma.
Immunohistochemical staining was made. Immunohisto-
chemical staining for CK-7(Cytokeratin-7), CK-20(Cytokeratin-
20), S-100 antibody, TTF-1(Thyroid transcription factor-1), EMA
(Epithelial membrane antigen), HMB-45 Antibody, NSE (Neu-
ron-speciﬁc enolase) and prostate speciﬁc antigen (PSA) were
performed on formalin-ﬁxed parafﬁn sections. PSA and NSE
were found positive, but the other markers were negative
(Fig. 2).
3. Discussion
Orbital metastasis of a neoplasm is an uncommon entity in
adults and it represents only 2–9% of orbital tumors [6,7]. The
ﬁrst case of metastatic prostatic carcinoma to the eye was
reported in 1872 [8]. There are two routes of metastasis to the
orbital region. The ﬁrst one is through lung metastases, where
tumor emboli pass via pulmonary circulation. Secondly,
prostatic or vertebral lesions may seed into Batson's plexus
and reach the cranial venous sinuses [5]. The most common
epithelial tumors are adenocarcinomas originating from the
breast, lung, prostate, stomach, thyroid, and kidney [4,5]. The
most common sites of metastasis beyond the periprostatic
region are the pelvic nodes and the pelvic, lumbosacral spine,
and long bones [5]. Soft-tissue metastases of prostate cancer are
very rare. Prostate carcinoma accounts for 3–10% of orbital
metastases encountered in clinical practice [9,10]. Review of the
literature, of 142 cases of metastases to the temporal bone from
distant primary malignancies, only 8 cases were found due to
prostate adenocarcinoma [11,12] and the other paper, they
found only a case secondary to prostate cancer out of 23 cases
with metastasis to the orbit [13]. The other series of 227 cases
with metastatic orbital tumor, only 3 cases were prostate cancer
history [14]. De Potter et al. published 7 cases with orbital
metastasis from prostate cancer [15]. The most common ﬁnding
on CT is a well-deﬁned, contrast enhancing, intraconal mass
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visual loss, ptosis, ocular pain, osteoblastic lesions of the orbital
wall and diplopia due to the orbital involvement. Ulucak et al.
reported that a case of prostatic cancer metastasizing to the left
orbital cavity. Neither Ulucak et al. are reported their case nor
the other cases presented dumb-bell metastases from prostate
cancer [6]. Due to the fact that patients with metastatic orbital
disease have poor prognosis; treatment is usually palliative and
may include radiotherapy, chemotherapy, surgery, or a combi-
nation of these modalities. The goal of surgical debulking is
usually palliative (i.e. to address morbid proptosis or optic
neuropathy). In cases of diagnostic uncertainty, an orbital
biopsy may be all that is necessary [16].
Our patient had a history of prostate adenocarcinoma
diagnosis 5 years ago. Histopathologic examination from the
orbital mass indicated a malignant epithelial tumor metasta-
sis that may have arose secondary to prostate carcinoma. Best
of our knowledge, prostate adenocarcinoma and its triple
orbital metastases that intraorbital mass (including periocular
structures), temporal bone and temporal muscle from prostate
cancer have not been published previously. Metastatic orbital
tumor secondary to prostate cancer should be considered in
patients who have varying degrees of eye symptoms. The
prognosis of orbital metastasis due to prostate cancer seems to
be better than the other oculo-orbital metastatic cancers [7].
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